Oxford University spin-out develops new test for heart disease
The CEO of a medtech spin-out from Oxford University has described how being paired with a group of experienced business mentors has helped his team commercialise a new way of diagnosing heart disease.
Founded by four Oxford cardiologists, Caristo Diagnostics has developed a new test that analyses routine heart scans for signs of inflammation in the coronary arteries, which supply blood to the heart. It’s known that inflammation in the coronary arteries is a key feature in the lead up to heart attacks.
You can read the write-up here.
Read more
April 2024
Newsweek Selects Caristo Diagnostics as One of World’s Best Digital Health Companies
Caristo Diagnostics, a leading cardiac disease diagnostics company, has been named by Newsweek as one of World’s Best Digital Health…
Read more
April 2024
Surrey Cardiovascular Clinic and Caristo Diagnostics Launch Employee Heart Wellness and Disease Prevention Program for UK Employers
Caristo’s AI technology predicts heart attack risk for employee wellness initiative from respected centre of excellence OXFORD, England and SURREY, England , April 23,…